Genfit SA (GNFT)
4.24
-0.07
(-1.62%)
USD |
NASDAQ |
Nov 21, 16:00
4.18
-0.06
(-1.42%)
After-Hours: 07:34
Genfit Price to Book Value: 2.028 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 21, 2024 | 2.028 |
November 20, 2024 | 2.061 |
November 19, 2024 | 2.038 |
November 18, 2024 | 2.090 |
November 15, 2024 | 2.152 |
November 14, 2024 | 2.169 |
November 13, 2024 | 2.491 |
November 12, 2024 | 2.492 |
November 11, 2024 | 2.501 |
November 08, 2024 | 2.501 |
November 07, 2024 | 2.730 |
November 06, 2024 | 2.676 |
November 05, 2024 | 2.769 |
November 04, 2024 | 2.754 |
November 01, 2024 | 2.812 |
October 31, 2024 | 2.798 |
October 30, 2024 | 2.798 |
October 29, 2024 | 2.635 |
October 28, 2024 | 2.635 |
October 25, 2024 | 2.630 |
October 24, 2024 | 2.673 |
October 23, 2024 | 2.726 |
October 22, 2024 | 2.867 |
October 21, 2024 | 2.843 |
October 18, 2024 | 2.840 |
Date | Value |
---|---|
October 17, 2024 | 3.027 |
October 16, 2024 | 3.003 |
October 15, 2024 | 2.826 |
October 14, 2024 | 2.922 |
October 11, 2024 | 2.898 |
October 10, 2024 | 2.650 |
October 09, 2024 | 2.654 |
October 08, 2024 | 2.671 |
October 07, 2024 | 2.611 |
October 04, 2024 | 2.576 |
October 03, 2024 | 2.534 |
October 02, 2024 | 2.461 |
October 01, 2024 | 2.421 |
September 30, 2024 | 2.855 |
September 27, 2024 | 2.726 |
September 26, 2024 | 2.683 |
September 25, 2024 | 2.573 |
September 24, 2024 | 2.525 |
September 23, 2024 | 2.386 |
September 20, 2024 | 2.314 |
September 19, 2024 | 2.004 |
September 18, 2024 | 2.075 |
September 17, 2024 | 2.023 |
September 16, 2024 | 1.977 |
September 13, 2024 | 1.961 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.142
Minimum
Jun 13 2022
9.074
Maximum
May 11 2020
3.205
Average
2.325
Median
Price to Book Value Benchmarks
Edap TMS SA | 1.940 |
DBV Technologies SA | 0.869 |
Cellectis SA | 1.438 |
Adaptimmune Therapeutics PLC | 2.036 |
Akari Therapeutics PLC | -- |
Price to Book Value Related Metrics
PE Ratio | 37.62 |
PS Ratio | 3.069 |
Price | 4.24 |
Earnings Yield | 2.66% |
Market Cap | 211.60M |
Operating PE Ratio | 19.78 |
Normalized PE Ratio | 40.29 |